Status: Recruiting
Bladder EpiCheck Product Development Study
This is a prospective, observational study to support the development of the Bladder EpiCheck kit by collecting urine samples from subjects suspected to have a bladder tumor or under NMIBC surveillance. This is a single visit study. Each subject will sign the informed consent and provide voided urine sample. Demography and, if performed, pathology information will be collected for each subject.
Participants needed: 1,000
Trial details
Age: 22+Biological sex: AllType: ObservationalSponsor: Nucleix Ltd.Updated: Apr 7, 2026Locations: 2
Eligibility criteria
Age 22 or older [+1]
Patients with known or history of muscle invasive bladder cancer (MIBC) [+2]